Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Republic Bancorp A | RBCAA | Oct 15, 2024 | 65.60 | +0.61 |
Republic Services | RSG | Oct 15, 2024 | 206.49 | +0.35 |
Research Frontiers | REFR | Oct 15, 2024 | 2.04 | +3.55 |
Research Solutions | RSSS | Oct 15, 2024 | 2.74 | +0.74 |
Reservoir Media | RSVR | Oct 15, 2024 | 8.87 | -0.67 |
ReShape Lifesciences | RSLS | Oct 15, 2024 | 5.66 | +5.79 |
Resideo Technologies | REZI | Oct 15, 2024 | 20.74 | -0.81 |
ResMed | RMD | Oct 15, 2024 | 239.18 | -0.64 |
Resources Connection | RGP | Oct 15, 2024 | 8.42 | +1.69 |
Restaurant Brands International | QSR | Oct 15, 2024 | 71.21 | -0.53 |
Retail Bull 3X Direxion | RETL | Oct 15, 2024 | 9.22 | +3.95 |
Retail ETF Market Vectors | RTH | Oct 15, 2024 | 220.86 | -0.21 |
Retail Opportunity Investments | ROIC | Oct 15, 2024 | 15.93 | +1.59 |
ReTo Eco-Solutions | RETO | Oct 15, 2024 | 1.15 | -0.43 |
Retractable Technologies | RVP | Oct 15, 2024 | 0.78 | +2.65 |
REV Group | REVG | Oct 15, 2024 | 28.12 | +0.93 |
Revance Therapeutics | RVNC | Oct 15, 2024 | 5.20 | +1.17 |
Revelation Biosciences | REVB | Oct 15, 2024 | 0.78 | -1.33 |
Revenueshares Largecap | RWL | Oct 15, 2024 | 99.20 | -0.45 |
Revenueshares Midcap | RWK | Oct 15, 2024 | 117.51 | -0.30 |
Revenueshares Smallcap | RWJ | Oct 15, 2024 | 45.58 | +0.02 |
Revenueshares Ultra Dividend Fund | RDIV | Oct 15, 2024 | 50.31 | +0.76 |
Reviva Pharmaceuticals | RVPH | Oct 15, 2024 | 1.23 | 0.00 |
Revolution Medicines | RVMD | Oct 15, 2024 | 48.99 | -0.47 |
Revolve Group A | RVLV | Oct 15, 2024 | 25.83 | +0.47 |
Revvity | RVTY | Oct 15, 2024 | 124.36 | +1.18 |
REX American Resources | REX | Oct 15, 2024 | 44.71 | -2.08 |
Rexford Industrial Realty | REXR | Oct 15, 2024 | 47.75 | +0.93 |
Rexford Industrial Realty B Pref | REXR-B | Oct 15, 2024 | 24.30 | +0.54 |
Rexford Industrial Realty C Pref | REXR-C | Oct 15, 2024 | 23.80 | +0.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.